Charles River Laboratories Intl. Inc vs Fiverr International Ltd — how do they compare? Charles River Laboratories Intl. Inc trades at $301.4 (market cap $14.23B), while Fiverr International Ltd trades at $8.59 (market cap $310.61M). The key difference: Charles River Laboratories Intl. Inc is far larger — about 45.8× Fiverr International Ltd's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Fiverr International Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Fiverr International Ltd for 62 Days on average.
| CRL | FVRR | |
|---|---|---|
Market Cap | $14.23B | $310.61M |
Volume | 1,176,885 | 381,459 |
Sector | Health | Media |
52-Week High | $310.77 | $23.60 |
52-Week Low | $149.93 | $8.47 |
Typical Hold Time | 33 Days | 62 Days |
Enterprise Value | $17.06B | $63.00M |
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $301.79, up 0.5% with strong analyst support (73% buy ratings) and a $305.50 consensus target. The stock shows bullish technical momentum above key support levels, though fundamentals reveal challenges with negative net income margins (-5.96%) and elevated P/E ratio (684.85). Recent quarterly earnings beats and a new 2030 growth strategy provide optimism, but profitability concerns persist amid flat revenue trends.
The outlook balances near-term technical strength against fundamental headwinds. Investment opportunity lies in execution of the 5-7% growth target and $300M savings plan, while risks include sustained negative profitability, high debt levels ($2.24B), and margin pressure. Current price near resistance at $304 suggests limited upside without fundamental improvement.
Fiverr International (FVRR) trades at $8.72, up 2.59% today, but remains under pressure with bearish technical signals and recent earnings misses. The company reported Q2 2026 revenue of $97.8 million, down 10% year-over-year, as AI disruption impacts demand for lower-value freelance work. Despite attractive valuation metrics (P/E 10.67, P/S 0.76), the stock faces headwinds from declining revenue and negative cash flow trends.
The outlook remains challenging with AI compression affecting core business, though current valuations appear discounted. Investment opportunity exists if Fiverr successfully adapts to AI disruption, but risks include continued revenue decline and competitive threats. Analyst consensus is cautious with 76% hold ratings and $10.50 price target suggesting limited upside from current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →